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Acting on incidental findings in research imaging
Incidental findings of imaging research studies can turn healthy individuals into anxious patients,
while putting an extra burden on primary care. J M Wardlaw and colleagues argue that doctors
should ensure that the personal, ethical, healthcare, and cost implications of these common findings
are managed proportionately, sensitively, and economically
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Medical imaging is commonly used in research and can lead to
major medical advances. However, it can also detect incidental
findings of “potential health importance, unknown to the
participant, unrelated to the purpose, and beyond the aims of
the research.”1 2Detecting incidental findings may be lifesaving
or may cause distress and uncertainty and affect livelihood.
Incidental findings increase the already high workloads of
general practitioners and hospital specialists.3 4 They have
immediate and emotive impact: participants know that the
researcher sees the images during scanning, so they expect that
incidental findings will be acted on, even when told otherwise.5
Researchers’ knowledge of incidental findings varies hugely.6 7
Little advice is available on what to do, despite calls for clarity
and for national frameworks.8-13 Efforts to establish guidance
on incidental findings by UK imaging researchers, the UK
Biobank Ethics and Governance Council, the Wellcome Trust,
the Medical Research Council, and the Health Research
Authority put the United Kingdom ahead of other countries,14-16
but gaps in our knowledge remain (box 1).
On average, 3% of healthy participants who undergo brain
imaging have incidental findings with health implications, rising
to nearer 30% over age 70 or with more sensitive imaging.17-24
Incidental findings in the chest or abdomen are found in 14%
to 50% of patients23 25 and 29% to 94% of volunteers,26 27
particularly with cardiac and colon imaging.28-30 Physiological
anomalies and artefacts may be misidentified as disease by
researchers without specialist medical training.
Major research initiatives in the UK (such the UK Biobank
Imaging study, with up to 100 000 participants), the United
States (the BRAIN Initiative),31 and many European countries
will soon scan several hundred thousand healthy participants,
generating many thousands of incidental findings. These will
have a huge impact on primary care and hospital services and
will bring research imaging into disrepute if the duty of care to
participants goes unrecognised.1
Here we discuss the wide ranging personal, ethical, healthcare,
and cost implications of incidental findings and suggest the path
forward to avoid turning healthy individuals into anxious
patients and burdening healthcare systems with even more
overdiagnoses.
Huge practical implications
Recognising potential abnormalities requires specific medical
expertise, but at least 40% of research imaging is undertaken
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Box 1: Knowledge gaps
Epidemiology of incidental findings with health consequences—Frequency, natural course, lifetime health, psychological and financial
consequences of incidental findings, including those that are age and gender specific
How to manage costs—Cost effectiveness of different management strategies
How research participants think about incidental findings—Attitudes of a wider cross section of research participants about management
Better ways to inform research participants about medical and non-medical implications—Methods to improve participant understanding
that further investigation and treatment may lead to substantial harm, not just benefit
How to improve engagement with healthcare providers—Hospital and primary care services should understand the practical and resource
implications and join the discussion on management
Non-medical implications—Psychological, emotional, and personal financial effects of different management strategies
by non-medically trained scientists, potentially leading to
incorrect diagnoses and costs to the participant, researchers, and
the NHS.6-8 10 31-34 Without clearly established management
pathways, the burden is likely to fall disproportionately on
primary care.
Delays adversely affect participants’ quality of life, insurance,
and work. Some incidental findings require medical intervention
and some trigger further investigations, both of which increase
cost, risk, and anxiety.35 36 For example, a volunteer with an
unsuspected ascending aortic aneurysm (but family history of
sudden death before age 40) benefited from intensive
management of cardiovascular risk factors (fig 1⇓). Other
examples include a young volunteer with unsuspected multiple
sclerosis who benefited from early prescription of disease
modifying therapy (fig 2⇓) and a volunteer with a liver lesion,
probably benign, who is now having annual liver magnetic
resonance imaging (MRI) to avoid biopsy (fig 3⇓). Another
volunteer with a third ventricular colloid cyst was given advice
in case symptoms developed (fig 4⇓). In another case a volunteer
had major restrictions placed on his pilot’s licence after imaging
detected an asymptomatic brainstem lesion, probably
developmental perivascular spaces (fig 5⇓).
What do participants expect?
Data from potential participants indicate that most want to be
informed of incidental findings with health relevance in person,
by an expert who knows what to do.5 37 38 In one study of 133
volunteers 41% said they would participate only if they received
feedback about all potential problems.39 In another study 79%
of 1105 respondents thought that the advantages of feedback
outweighed the disadvantages, regardless of curability, 71%
thought that feedback should be included in the consent process,
60-70% recognised inaccurate findings or loss of insurance as
among the main disadvantages, and most thought that it was
acceptable to override refusal to receive feedback if the condition
was potentially life threatening.5
The attitudes of those who have participated in research vary.
When 1672 participants in UK Biobank were told that planned
additional brain and body imaging would not be a health check,
would be stored for future research, and would not be reviewed
routinely, but that their doctor would be notified if a potentially
serious abnormality was noticed during scanning, 1572 of them
(92%) agreed to participate.40 In a longitudinal study of atheroma
only 0.02% of 4500 participants aged 40-54 asked not to receive
feedback.41 We need more data on participants’ understanding
and experiences of research imaging.
Natural course is unknown
Predicting prognosis of incidental findings would be more
accurate if our knowledge of prevalence by age, natural course,
and medical implications had progressed at the same pace as
the sensitivity of imaging technologies. But for many incidental
findings the benefit versus risk of early diagnosis and treatment
is unknown. Only five studies provide data on long term natural
course of incidental findings detected during research imaging.
In a retrospective analysis of 1000 healthy participants aged
3-83 years who had brain MRI, 180 had incidental findings, 18
of whomwent for routine assessment and 11 for urgent medical
assessment—but the outcomes are unknown.42 In another study
32% of 750 volunteers aged 71-74 had an abnormal brain scan,
2% went for further assessment, and none received treatment.18
Incidental findings on body imaging are investigated and treated
more often than those on brain imaging. Twenty four of 124
(18%) incidental findings in 132 healthy doctors on whole body
MRI were investigated: five were tumours, of which two were
malignant.27 Fifteen of 101 (15%) incidental findings in 254
volunteers on coronary magnetic resonance angiography were
referred for further imaging.29 In a study of 2500 community
participants who had whole bodyMRI, 1052 incidental findings
were confirmed and fed back to the participants, 62 of which
(6%) were malignant, 383 (36%) were benign, 607 (58%) were
unclear, and only 9 (0.7%) were treated.22
Legal precedents are unclear
How the medical profession responds to research detected
incidental findings is important. In the absence of a legal “test
case” in the UK, courts will take common practice and relevant
professional bodies’ views into account, enabling the profession
to influence legal precedent.43 44 Although doctors and other
healthcare professions have a well established duty of care to
tell patients about clinically relevant findings, its scope is less
well defined for research or for findings of unknown
relevance.4 44 45 Some duty of care in research undoubtedly
exists—what constitutes a reasonable standard of care depends
on what responsible peers consider acceptable. It may be
informed by the researcher’s professional status, experience,
and potential to prevent harm.
Reasonable care in research is likely to include informing
participants of treatable incidental findings and enabling them
to benefit from earlier, perhaps more effective, treatment.44
Many would argue that the absence of a clear, ethically sound,
transparent policy on incidental findings is irresponsible. What
if a lesion that could precipitate epilepsy was seen in a
commercial driver who had refused feedback? The response
should be measured, proportionate to risks (including risks to
research), based on actual rather than perceived risks, and should
avoid increasing the administration and cost of research and
overdiagnoses.
Who pays?
UK primary care currently carries the major burden of referring
and counselling the worried, previously healthy participant who
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has become a patient based on incidental findings. Total costs
and cost effectiveness of managing incidental findings are
unknown.28 46 47 The Wellcome Trust and MRC have agreed to
support the costs of providing feedback on incidental findings
in research that they fund, but identification is only the first step
and much imaging research is funded by bodies who have not
made such a commitment.48-50
Countries where private healthcare predominates may
inadvertently be fostering “research tourism.” Worried
individuals might participate in imaging research for the “free
scan,” not knowing that the imaging may be inappropriate, that
the researchers may not be competent to interpret the findings,
or the cost implications of any additional management of
incidental findings.
What now?
We must acknowledge the existence of research detected
incidental findings and implement pragmatic and proportionate
ways of dealing with them. The expectations of participants
should be managed to avoid research imaging being seen as a
“health check” and to prevent false reassurance if no feedback
is received.44 51 They should understand the potential for anxiety,
health, and personal financial risks.4 10
Radiologist review of incidental findings is impractical owing
to the high rates of research imaging, insufficient radiologists
with already large clinical demands, and expense.7 Remote
review of images via a network of trained individuals who
provide quick advice on findings has worked in some places
but needs organisation and incurs cost.52 No alternatives are in
widespread use.53-56 Perhaps non-expert researchers could benefit
from a list of common incidental findings with their health
implications. But such a list needs developing, validating, and
testing for legal implications, with the associated costs, and
requires more knowledge of natural course.
A workshop of UK researchers, professional organisations,
ethicists, and funders of imaging research in 2011 developed
six working principles to aid planning around research detected
incidental findings (box 2).14 We may need mechanisms for
handling new health implications of former research
findings—for example, features subsequently found to be
treatable with new interventions—which raises questions of
dynamic consent and re-identification mechanisms.57
Further discussion on management of incidental findings must
include NHS representatives (and relevant representatives from
other countries) who, with a few exceptions, have largely been
omitted from the debate.14 Incidental findings should be part of
good clinical practice training. New research imaging centres
should plan for medical input to research imaging.7
We depend on the public for participants in research; they should
understand the implications of sensitive imaging technologies
so they can interact with them in an informed way. Participants
should understand that all research, while potentially conferring
major societal benefits, carries risks, and that detailed feedback
can have a negative impact on both research and health services.
Responsible use of powerful research technologies now demands
national foresight and proactive informed debate to promote
trust in research, and the results, without unduly encumbering
the scientific process.1
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Box 2: Reasonable principles for management of incidental findings in research
Transparency—Acknowledge the frequency and type of incidental findings likely to be encountered in the research and explain in
protocols and to ethics committees the procedures for identifying, managing, and informing participants about such findings. Study
information sheets and consent procedures should be clear on risk of, and procedures for managing, incidental findings
Expectations—Participants should know what to expect regarding frequency, type, identification, disclosure, further medical management,
and personal implications of incidental findings. Participant input to study design, information sheets, and consent processes is important
Duty of care—The legal parameters of researcher duty of care remain under debate and untested in the UK. In the meantime, imaging
research centres should have a clear policy on management of incidental findings and should communicate this to research participants
at the time of recruitment, not only at the scanner. Researchers should avoid feeding back unverified results without an action plan, as
this may increase anxiety
Resources—Resources are finite, so funders, ethics committees, research administrators, and healthcare providers should all be aware
of staff and financial constraints
Flexibility—Relevant management will vary with research question, participant characteristics, researcher background, and integration
with clinical services
Evolving field—Imaging technologies are increasingly sophisticated; medical knowledge advances rapidly; ambitious population imaging
studies, expectations and rights of the individual, and access to medical information, all contribute to changing detection and implications
of research incidental findings
Key messages
The burden of managing incidental findings detected by research imaging falls heavily on primary care (referral, counselling, treatment,
etc)
Little advice is available on how to manage incidental findings, and legal precedents are yet to be established
We need more data on their natural course, the cost effectiveness of management strategies, and the attitudes of a cross section of
research participants
Research participants should be supported to develop realistic expectations on the likelihood of detection and potential implications of
incidental findings as part of the consent process
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Figures
Fig 1 Unsuspected ascending aortic aneurysm detected in volunteer. All the first degree male relatives had died suddenly
before the age of 40, and intensive cardiovascular management was started
Fig 2 Axial FLAIR (left) and T2 (right) brain MRI show multiple lesions consistent with multiple sclerosis in a young health
technologist, who benefited from early treatment
Fig 3 Uncertain liver mass in volunteer required annual follow-up. A 40 year old volunteer had a solid liver lesion found
during a renal research MRI examination. A diagnostic MRI (left) suggested either focal nodular hyperplasia or adenoma.
Annual follow-up examination at two years (right) showed lesion growth and atypical features. A biopsy to exclude adenoma
(which carries a small risk of malignant change and spontaneous haemorrhage) was declined. The volunteer continues
with annual follow-up MRI examinations
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Fig 4 Third ventricular colloid cyst detected in research volunteer enabled advice to be given on how to respond to symptoms
Fig 5 Adverse effect on employment for research volunteer. MRI showed a cluster of prominent perivascular spaces in the
pons, initially interpreted as an ischaemic stroke despite absence of symptoms. This led to major restrictions on his pilot’s
licence
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